Glucagon-Like Peptide-1 Receptor Agonist Ameliorates 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP) Neurotoxicity Through Enhancing Mitophagy Flux and Reducing α-Synuclein and Oxidative Stress

Parkinson disease (PD) is the second most common neurodegenerative disease without known disease modification therapy to slow down disease progression. This disease has pathological features of Lewy bodies with α-synuclein aggregation being the major component and selective dopaminergic neuronal los...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tsu-Kung, Lin, Kai-Jung, Lin, Hung-Yu, Lin, Kai-Lieh, Lan, Min-Yu, Wang, Pei-Wen, Wang, Tzu-Jou, Wang, Feng-Sheng, Tsai, Po-Chin, Liou, Chia-Wei, Chuang, Jiin-Haur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292641/
https://www.ncbi.nlm.nih.gov/pubmed/34305527
http://dx.doi.org/10.3389/fnmol.2021.697440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292641/
https://www.ncbi.nlm.nih.gov/pubmed/34305527
http://dx.doi.org/10.3389/fnmol.2021.697440

Ejemplares similares